We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$16.8B
AUM Growth
+$94M
(+0.56%)
Cap. Flow
-$533M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
17.18%
Holding
362
New
38
Increased
90
Reduced
146
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$166M |
| 2 |
Trane Technologies
TT
|
+$136M |
| 3 |
Estee Lauder
EL
|
+$102M |
| 4 |
Celanese
CE
|
+$101M |
| 5 |
Oracle
ORCL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$172M |
| 2 |
ARTC
ARTHROCARE CORP
ARTC
|
+$118M |
| 3 |
eBay
EBAY
|
+$109M |
| 4 |
Ecolab
ECL
|
+$107M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
+$86.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Industrials | 14.66% |
| 3 | Technology | 14.16% |
| 4 | Communication Services | 9.98% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NORD
226
DELISTED
Nord Anglia Education, Inc.
NORD
| $13.2M | 0.08% |
+718,749
| New | +$13.3M |
|
227
Rush Enterprises Class A
RUSHA
$6.33B
| $12.8M | 0.08% |
+831,341
| New | +$12.3M |
|
|
INVN
228
DELISTED
Invensense Inc
INVN
| $11.6M | 0.07% |
509,175
-220,620
| -30% | -$4.51M |
|
229
Viavi Solutions
VIAV
$9.81B
| $11.2M | 0.07% |
1,585,537
-3,471,693
| -69% | -$23.6M |
|
230
Rogers Corp
ROG
$2.33B
| $11M | 0.07% |
+166,490
| New | +$10.3M |
|
|
CMLS
231
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $10.3M | 0.06% |
196,110
-1,871
| -0.9% | -$97.6K |
|
232
Gentex
GNTX
$5.02B
| $8.78M | 0.05% |
603,916
-1,543,134
| -72% | -$22.5M |
|
|
CCXI
233
DELISTED
ChemoCentryx, Inc.
CCXI
| $8.2M | 0.05% |
1,400,993
-1,310
| -0.1% | -$7.35K |
|
234
GE Aerospace
GE
$387B
| $8.09M | 0.05% |
64,223
-2,561
| -4% | -$326K |
|
|
CSOD
235
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $7.92M | 0.05% |
172,195
+1,790
| +1% | +$72.8K |
|
|
GRMN
236
Garmin
GRMN
$58.6B
| $6.17M | 0.04% |
101,280
+3,410
| +3% | +$196K |
|
237
Occidental Petroleum
OXY
$54.2B
| $5.61M | 0.03% |
57,089
-20,568
| -26% | -$1.93M |
|
|
STAY
238
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $5.25M | 0.03% |
226,450
-1,560
| -0.7% | -$35.1K |
|
|
NGHC
239
DELISTED
National General Holdings Corp
NGHC
| $5.07M | 0.03% |
+291,450
| New | +$4.44M |
|
240
Enovis
ENOV
$1.78B
| $4.49M | 0.03% |
34,987
-5,851
| -14% | -$731K |
|
|
241
Bristol-Myers Squibb
BMY
$132B
| $4.16M | 0.02% |
85,660
-3,488,354
| -98% | -$172M |
|
242
Johnson & Johnson
JNJ
$607B
| $2.87M | 0.02% |
27,450
| – | – |
|
243
Pfizer
PFE
$142B
| $2.81M | 0.02% |
99,619
+25,064
| +34% | +$714K |
|
244
United Parcel Service
UPS
$90.7B
| $2.53M | 0.02% |
+24,680
| New | +$2.48M |
|
245
Air Products & Chemicals
APD
$65B
| $2.29M | 0.01% |
19,226
+2,941
| +18% | +$328K |
|
246
Analog Devices
ADI
$183B
| $2.21M | 0.01% |
40,780
+7,680
| +23% | +$406K |
|
|
EV
247
DELISTED
Eaton Vance Corp.
EV
| $2.18M | 0.01% |
57,729
-55,750
| -49% | -$2.06M |
|
|
CORV
248
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $2.18M | 0.01% |
277,164
-22,900
| -8% | -$173K |
|
249
American Water Works
AWK
$25.9B
| $2.13M | 0.01% |
43,170
+8,130
| +23% | +$382K |
|
250
Jack Henry & Associates
JKHY
$11.1B
| $2.09M | 0.01% |
35,140
+6,620
| +23% | +$378K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Westfield Capital Management held 362 positions worth $16.8B, up 0.56% from $16.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $533M in Q2 2014, closing 50 positions and reducing 146 holdings. Its most notable exit was ARTHROCARE CORP, an estimated $118M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
Against the trend, Westfield Capital Management opened a new position in Trane Technologies worth $143M.
- Westfield Capital Management's largest Q2 2014 buy was Trane Technologies: 2,294,021 shares worth $143M.
- Westfield Capital Management added most to Verizon in Q2 2014, an estimated $166M increase.
- Westfield Capital Management's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $172M.
- Westfield Capital Management fully exited ARTHROCARE CORP in Q2 2014, selling an estimated $118M.
- Westfield Capital Management's ten largest holdings make up 17% of its $16.8B portfolio in Q2 2014.
- Westfield Capital Management opened 38 new positions and closed 50 in Q2 2014.
- Westfield Capital Management's portfolio value rose 0.56% quarter-over-quarter to $16.8B.
Based on Westfield Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.